Since 2000, the United States Food and Drug Administration (FDA) has regulated reprocessors of so-called “single-use” medical devices (SUDs) as medical device manufacturers, subjecting all reprocessors (third-party, hospital, and original equipment manufacturers (OEMs)) to all of the agency’s medical device manufacturer requirements. Thus, FDA’s regulatory framework for reprocessing is perhaps the longest-standing, most comprehensive in the world.  However, the U.S. is not the only nation to address the reprocessing of SUDs.

This summary outlines, to the best of AMDR’s knowledge, the legal and regulatory status of SUD reprocessing in a number of jurisdictions, including the European Union (EU), Australia, Canada, South Korea, Saudi Arabia, and Israel.

Read the Full Summary

Follow us on Twitter and Facebook for all the latest updates related to reprocessing!